Moderna Covid Vaccine
-
{
- All
- News
-
Moderna's New Bivalent Omicron Jab Shows "Positive Results" In Trials
US biotech company Moderna on Wednesday announced positive results for a new vaccine that targets both the original Covid strain and Omicron.
-
Moderna Seeks US Approval For Covid Vaccine For Children Under 6
US biotech firm Moderna said Thursday it had submitted a request for an emergency use authorization in the United States for its Covid vaccine for children aged six months to under six years.
-
US Gives Full Approval To Moderna's COVID-19 Vaccine For Adults
The US Food and Drug Administration (FDA) announced Monday that it has granted full approval to Moderna's COVID19 "Spikevax" vaccine, which had previously received an emergency use authorization in the United States.
-
Moderna Begins Omicron-Specific Vaccine Trials After Pfizer-BioNTech
US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus.
-
EU Drug Watchdog Backs Moderna Booster For All Over-18s
The EU's drug watchdog on Monday approved booster doses of Moderna's Covid vaccine for all over-18s, amid concerns that protection levels dip after initial jabs.
-
Moderna Says Its Covid Vaccine Protective, Safe In Young Children
Moderna Inc said on Monday its COVID-19 vaccine generated a strong immune response and was generally well-tolerated in children aged six to 11 years, citing interim data from a study.
-
Iceland Suspends Moderna Covid Vaccine Over Heart-Inflammation Fears
Iceland on Friday suspended the Moderna anti-Covid vaccine, citing the slight increased risks of cardiac inflammation, going further than its Nordic neighbours which simply limited use of the jabs.
-
Tainted Covid Vaccines Sent To Japan Contained Steel: Moderna Amid Furore
Moderna said Wednesday that tainted batches of its Covid-19 vaccine sent to Japan were contaminated with stainless steel particles, but the company did not expect it posed "an undue risk to patient safety."
-
Moderna Says Covid Vaccine "Highly Effective" In Adolescents
US biotech firm Moderna said Tuesday that trials had shown its Covid-19 vaccine is "highly effective" in adolescents aged 12-17 and the company would seek regulators' approval in June.
-
Enough Covid Vaccine For 300 Million Americans By End Of Summer: Official
The US government is purchasing an additional 200 million doses of Covid-19 vaccine and will have enough to vaccinate 300 million Americans by the end of the summer, a senior administration official said Tuesday.
-
UK Secures Additional 2 Million Doses Of Moderna Covid Vaccine
Britain has secured an additional two million doses of Moderna Inc's COVID-19 vaccine candidate, the government said in a statement on Sunday.
-
Moderna Says Vaccine Stable At Refrigerator Temperatures For 30 Days
Moderna Inc. said its Covid-19 vaccine was 94.5% effective in a preliminary analysis of a large late-stage clinical trial, another sign that a fast-paced hunt by scientists and pharmaceutical companies is paying off with potent new tools that could help control a worsening pandemic.
-
"Stunningly Impressive": Top US Expert On Moderna Covid Vaccine Results
The United States' top infectious disease scientist on Monday hailed early results from Moderna's Covid-19 vaccine trial as "stunningly impressive," calling the findings an emphatic validation of experimental mRNA technology that some had doubted.
-
UK Pharma Firm Moderna Says Prepping For Launch Of Experimental COVID Vaccine
Moderna, one of the front-runners in the race to develop a vaccine for the new coronavirus, said on Thursday it was preparing to launch the experimental vaccine and had already received $1.1 billion in deposits for supply.
-
Moderna's New Bivalent Omicron Jab Shows "Positive Results" In Trials
US biotech company Moderna on Wednesday announced positive results for a new vaccine that targets both the original Covid strain and Omicron.
-
Moderna Seeks US Approval For Covid Vaccine For Children Under 6
US biotech firm Moderna said Thursday it had submitted a request for an emergency use authorization in the United States for its Covid vaccine for children aged six months to under six years.
-
US Gives Full Approval To Moderna's COVID-19 Vaccine For Adults
The US Food and Drug Administration (FDA) announced Monday that it has granted full approval to Moderna's COVID19 "Spikevax" vaccine, which had previously received an emergency use authorization in the United States.
-
Moderna Begins Omicron-Specific Vaccine Trials After Pfizer-BioNTech
US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus.
-
EU Drug Watchdog Backs Moderna Booster For All Over-18s
The EU's drug watchdog on Monday approved booster doses of Moderna's Covid vaccine for all over-18s, amid concerns that protection levels dip after initial jabs.
-
Moderna Says Its Covid Vaccine Protective, Safe In Young Children
Moderna Inc said on Monday its COVID-19 vaccine generated a strong immune response and was generally well-tolerated in children aged six to 11 years, citing interim data from a study.
-
Iceland Suspends Moderna Covid Vaccine Over Heart-Inflammation Fears
Iceland on Friday suspended the Moderna anti-Covid vaccine, citing the slight increased risks of cardiac inflammation, going further than its Nordic neighbours which simply limited use of the jabs.
-
Tainted Covid Vaccines Sent To Japan Contained Steel: Moderna Amid Furore
Moderna said Wednesday that tainted batches of its Covid-19 vaccine sent to Japan were contaminated with stainless steel particles, but the company did not expect it posed "an undue risk to patient safety."
-
Moderna Says Covid Vaccine "Highly Effective" In Adolescents
US biotech firm Moderna said Tuesday that trials had shown its Covid-19 vaccine is "highly effective" in adolescents aged 12-17 and the company would seek regulators' approval in June.
-
Enough Covid Vaccine For 300 Million Americans By End Of Summer: Official
The US government is purchasing an additional 200 million doses of Covid-19 vaccine and will have enough to vaccinate 300 million Americans by the end of the summer, a senior administration official said Tuesday.
-
UK Secures Additional 2 Million Doses Of Moderna Covid Vaccine
Britain has secured an additional two million doses of Moderna Inc's COVID-19 vaccine candidate, the government said in a statement on Sunday.
-
Moderna Says Vaccine Stable At Refrigerator Temperatures For 30 Days
Moderna Inc. said its Covid-19 vaccine was 94.5% effective in a preliminary analysis of a large late-stage clinical trial, another sign that a fast-paced hunt by scientists and pharmaceutical companies is paying off with potent new tools that could help control a worsening pandemic.
-
"Stunningly Impressive": Top US Expert On Moderna Covid Vaccine Results
The United States' top infectious disease scientist on Monday hailed early results from Moderna's Covid-19 vaccine trial as "stunningly impressive," calling the findings an emphatic validation of experimental mRNA technology that some had doubted.
-
UK Pharma Firm Moderna Says Prepping For Launch Of Experimental COVID Vaccine
Moderna, one of the front-runners in the race to develop a vaccine for the new coronavirus, said on Thursday it was preparing to launch the experimental vaccine and had already received $1.1 billion in deposits for supply.
